Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 402, pg 775, 2023)

被引:0
作者
Pozo-Rosich, P.
Ailani, J.
Ashina, M.
机构
关键词
D O I
10.1016/S0140-6736(23)02236-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1328 / 1328
页数:1
相关论文
共 1 条
[1]   Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo- controlled, phase 3 trial [J].
Pozo-Rosich, Patricia ;
Ailani, Jessica ;
Ashina, Messoud ;
Goadsby, Peter J. ;
Lipton, Richard B. ;
Reuter, Uwe ;
Guo, Hua ;
Schwefel, Brittany ;
Lu, Kaifeng ;
Boinpally, Ramesh ;
Miceli, Rosa ;
Ferreira, Rosa De Abreu ;
Mccusker, Emily ;
Yu, Sung Yun ;
Severt, Lawrence ;
Finnegan, Michelle ;
Trugman, Joel M. .
LANCET, 2023, 402 (10404) :775-785